MDM-2 protein is expressed in different layers of normal human skin

Archive ouverte

Dazard, J. E. | Augias, D. | Neel, H. | Mils, V. | Marechal, V. | Basset-Seguin, N. | Piette, J.

Edité par CCSD ; Nature Publishing Group [1987-....] -

International audience. MDM-2 is one of the target genes of the p53 tumor suppressor protein. Its best characterized function is found in the inhibition of p53's ability to modulate transcription. Deregulated expression of MDM-2 could thus at least partially substitute for p53 mutation in the process of tumorigenesis. We show here that MDM-2 is highly expressed in biopsies of normal human skin or in vitro reconstituted human skin. The protein is detected in the nucleus of keratinocytes throughout the different layers of the epidermis and in reconstituted skin as early as the two to three cell layer stage. The 90 kiloDalton (kD) protein is one of the major forms detected in Western blot experiments. MDM-2 is detected in skin reconstituted from keratinocytes in which p53 is inactivated by mutation or degradation by E6 protein, providing evidence that MDM-2 expression in the skin can occur in the absence of wild type p53. Moreover, we found no correlation between the p53 status and MDM-2 expression levels in a series of basal and squamous cell carcinomas or Bowen diseases. Our data provide first evidence for the expression of MDM-2 in a differentiated adult tissue.

Consulter en ligne

Suggestions

Du même auteur

MDM2 expression in normal and pathological skin

Archive ouverte | Augias, D. | CCSD

International audience

Switch from p53 to MDM2 as differentiating human keratinocytes lose their proliferative potential and increase in cellular size

Archive ouverte | Dazard, J. E. | CCSD

International audience. p53 transcription factor is mutated in most skin cell carcinomas and in more than 50% of all human malignancies. One of its transcriptional targets is MDM2, which in turn down-regulates p53. ...

Skin as a potential organ for ectopic monoclonal antibody production

Archive ouverte | Noel, D. | CCSD

International audience. The therapeutic potential of monoclonal antibodies for treating a variety of severe or life-threatening diseases is high. Although intravenous infusion appears the simplest and most obvious m...

Chargement des enrichissements...